Skip to content

Improving Quality Based on the Joint Registry

Improving Quality Based on the Joint Registry

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04055103
Acronym
IQ Joint
Enrollment
20
Registered
2019-08-13
Start date
2019-08-01
Completion date
2021-05-31
Last updated
2021-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Arthropathy, Hospital Performance, Knee Arthropathy, Quality Improvement, Registries

Keywords

Total Hip/Knee Arthroplasty;Dutch Arthroplasty Register; Quality Improvement.

Brief summary

Test whether an intervention, consisting of frequently feedback of performance outcomes and education will improve patient care, expressed in better functional outcomes, fewer complications and more quality improving interventions.

Detailed description

A randomized controlled trial will be conducted where hospitals will be randomized to an early versus late group, stratified by teaching status as this might influence the time available for quality improvement. Randomization will be done using a computer generated randomization table in a 1:1 ratio. During the study only orthopedic surgeons performing THA and TKA will receive monthly feedback by email. The intervention will consist of the following components: * Monthly feedback of performance outcomes; * Education on how to use joint registry data for quality improvement; * Create awareness by sending monthly feedback about performance; education and by asking what improvement activities have been introduced; * Hospitals will be linked to hospital with opposite performance outcomes to exchange information and find areas for improvement. During the trial, the investigators will conduct monthly measurement on intermediate outcomes showing whether the intervention reaches the target group (process evaluation). The following measurements will take place: * Knowledge among orthopaedic surgeons on their recent performance and how that relates to others; * Number of quality improvement activities undertaken with the aim to improve the quality of care; * Planned improvement activities (e.g. record review to figure out why performance is not as good as in other centers) together with who is responsible and by which time; * Number of people attending the meetings, number of times a specific account has accessed the LROI site to ensure that information has reached the target group; * Survey among orthopaedic surgeons at the end of the intervention period on knowledge learned and the extent to which they think this is sustainable in daily practice. In addition, the investigators will compare the outcomes between the early and the late group to test the effectiveness of the intervention, using the appropriate regression techniques. In the second period the investigators will test the sustainability of this approach in daily practice by comparing the outcomes within the early group with the first period, and compare with the late group to test whether outcomes in the sustainability phase are similar as when actively supported.

Interventions

OTHERMonthly feedback, education and linking hospitals

\- Give monthly feedback from LROI-data (revision rate & patient reported outcome measures) as well as other outcomes from the participating hospital (length-of-stay, readmission and complications), combined with education on how to use this information for improvement. This will be send monthly by email to the intervention group. Further, hospitals with worse performance for a certain outcome will be linked to hospitals with good performance for this outcome.

Sponsors

Leiden University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)

Intervention model description

Each arm will receive the intervention for 6 months.

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* All Dutch orthopedic clinics where hip- and knee replacement surgery is performed who agree to participate will be randomized.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Prolonged length-of stay (yes/no)1 year follow-up during trialProlonged length-of-stay in the overall upper quartile
Survival (yes/no)1 year follow-up during trialPatient survival after HA/TKA surgery
1-year revision rate (%)1 year follow-up during trialNumber of revisions performed within one year adjusted for patient characteristics
Composite outcome measure (Textbook Outcome)1 year follow-up during trialIncluding: Survival; 1-year revision rate; Length-of-Stay and Readmission.
Readmission (yes/no)1 year follow-up during trialReadmission within 30 days after discharge
Number of Complications1 year follow-up during trialNumber of complications

Secondary

MeasureTime frameDescription
Number of Quality Improvement Initiatives1 year follow-up during trialNumber of quality improvement Initiatives with the aim to improve the quality of care

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026